Journal of Gastric Cancer

The Korean Gastric Cancer Association (대한위암학회)
권호 표지
DOI QR코드

DOI QR Code

Sarcopenia and Post-Operative Morbidity and Mortality in Patients with Gastric Cancer

  • O'Brien, Stephen (Department of Surgery, Mercy University Hospital) ;
  • Twomey, Maria (Department of Radiology, Cork University Hospital) ;
  • Moloney, Fiachra (Department of Radiology, Cork University Hospital) ;
  • Kavanagh, Richard G. (Department of Radiology, Cork University Hospital) ;
  • Carey, Brian W. (Department of Radiology, Cork University Hospital) ;
  • Power, Derek (Department of Medical Oncology, Mercy Cork University Hospitals) ;
  • Maher, Michael M. (Department of Radiology, Cork University Hospital) ;
  • O'Connor, Owen J. (Department of Radiology, Cork University Hospital) ;
  • O'Suilleabhain, Criostoir (Department of Surgery, Mercy University Hospital)
  • Received : 2018.04.27
  • Accepted : 2018.07.30
  • Published : 2018.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Surgical resection for gastric adenocarcinoma is associated with significant post-operative morbidity and mortality. The aim of this study was to assess the prognostic significance of sarcopenia in patients undergoing resection for gastric adenocarcinoma with respect to post-operative morbidity and survival. Materials and Methods: A retrospective analysis was conducted on a cohort of consecutive patients who underwent surgical resection for gastric adenocarcinoma between 2008 and 2014. Patient demographics, radiological parameters, and pathological data were collected. OsiriX software (Pixmeo) was used to measure skeletal muscle area, which was normalized for height to calculate skeletal muscle index. Results: A total of 56 patients (41 male, 15 female; mean age, $68.4{\pm}11.9years$) met the inclusion criteria. Of these, 36% (20 of 56) of the patients were sarcopenic pre-operatively. Both sarcopenic and non-sarcopenic patient groups were equally matched with the exception of weight and body mass index (P=0.036 and 0.001, respectively). Sarcopenia was associated with a decreased overall survival (log-rank P=0.003) and was an adverse prognostic predictor of overall survival in multivariate analysis (hazard ratio, 10.915; P=0.001). Sarcopenia was a predictor of serious in-hospital complications in multivariate analysis (odds ratio, 3.508; P=0.042). Conclusions: In patients undergoing curative resection for gastric cancer, there was a statistically significant association between sarcopenia and both decreased overall survival and serious post-operative complications. The measurement and reporting of skeletal muscle index on pre-operative computed tomography should be considered.

Keywords

References

  1. Ferlay JS, Soerjomataram I, Ervik M, Forman D, Bray F, Dikshit R, et al. GLOBOCAN 2012: cancer incidence, and mortality and prevalence worldwide in 2012 [Internet]. Lyon: International Agency for Research on Cancer; 2012 [cited 2014 Nov 14]. Available from: http://globocan.iarc.fr.
  2. National Cancer Institute. Surveillance, epidemiology, and end results program. Cancer stat facts: stomach cancer [Internet]. Bethesda (MD): National Cancer Institute; [cited 2017 Nov 10]. Available from: https://seer.cancer.gov/statfacts/html/stomach.html.
  3. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355:11-20. https://doi.org/10.1056/NEJMoa055531
  4. Bosing NM, Goretzki PE, Roher HD. Gastric cancer: which patients benefit from systematic lymphadenectomy? Eur J Surg Oncol 2000;26:498-505. https://doi.org/10.1053/ejso.1999.0930
  5. Selby LV, Vertosick EA, Sjoberg DD, Schattner MA, Janjigian YY, Brennan MF, et al. Morbidity after total gastrectomy: analysis of 238 patients. J Am Coll Surg 2015;220:863-871.e2. https://doi.org/10.1016/j.jamcollsurg.2015.01.058
  6. Lieffers JR, Bathe OF, Fassbender K, Winget M, Baracos VE. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer 2012;107:931-936. https://doi.org/10.1038/bjc.2012.350
  7. Harimoto N, Shirabe K, Yamashita YI, Ikegami T, Yoshizumi T, Soejima Y, et al. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg 2013;100:1523-1530. https://doi.org/10.1002/bjs.9258
  8. Reisinger KW, van Vugt JL, Tegels JJ, Snijders C, Hulsewe KW, Hoofwijk AG, et al. Functional compromise reflected by sarcopenia, frailty, and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery. Ann Surg 2015;261:345-352. https://doi.org/10.1097/SLA.0000000000000628
  9. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010;39:412-423. https://doi.org/10.1093/ageing/afq034
  10. Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol 2010;17:3077-3079. https://doi.org/10.1245/s10434-010-1362-z
  11. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383. https://doi.org/10.1016/0021-9681(87)90171-8
  12. Wolters U, Wolf T, Stutzer H, Schroder T. ASA classification and perioperative variables as predictors of postoperative outcome. Br J Anaesth 1996;77:217-222. https://doi.org/10.1093/bja/77.2.217
  13. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009;250:187-196. https://doi.org/10.1097/SLA.0b013e3181b13ca2
  14. Waddell T, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D, et al. Gastric cancer: ESMOESSO- ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;24 Suppl 6:vi57-vi63.
  15. Dello SA, Lodewick TM, van Dam RM, Reisinger KW, van den Broek MA, von Meyenfeldt MF, et al. Sarcopenia negatively affects preoperative total functional liver volume in patients undergoing liver resection. HPB 2013;15:165-169. https://doi.org/10.1111/j.1477-2574.2012.00517.x
  16. Mitsiopoulos N, Baumgartner RN, Heymsfield SB, Lyons W, Gallagher D, Ross R. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol (1985) 1998;85:115-122. https://doi.org/10.1152/jappl.1998.85.1.115
  17. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 2008;9:629-635. https://doi.org/10.1016/S1470-2045(08)70153-0
  18. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998;147:755-763. https://doi.org/10.1093/oxfordjournals.aje.a009520
  19. Voron T, Tselikas L, Pietrasz D, Pigneur F, Laurent A, Compagnon P, et al. Sarcopenia impacts on shortand long-term results of hepatectomy for hepatocellular carcinoma. Ann Surg 2015;261:1173-1183. https://doi.org/10.1097/SLA.0000000000000743
  20. Joglekar S, Asghar A, Mott SL, Johnson BE, Button AM, Clark E, et al. Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinoma. J Surg Oncol 2015;111:771-775. https://doi.org/10.1002/jso.23862
  21. Blum D, Stene GB, Solheim TS, Fayers P, Hjermstad MJ, Baracos VE, et al. Validation of the Consensus- Definition for Cancer Cachexia and evaluation of a classification model--a study based on data from an international multicentre project (EPCRC-CSA). Ann Oncol 2014;25:1635-1642. https://doi.org/10.1093/annonc/mdu086
  22. Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, et al. Cachexia: a new definition. Clin Nutr 2008;27:793-799. https://doi.org/10.1016/j.clnu.2008.06.013
  23. Tegels JJ, van Vugt JL, Reisinger KW, Hulsewe KW, Hoofwijk AG, Derikx JP, et al. Sarcopenia is highly prevalent in patients undergoing surgery for gastric cancer but not associated with worse outcomes. J Surg Oncol 2015;112:403-407. https://doi.org/10.1002/jso.24015
  24. Tan BH, Brammer K, Randhawa N, Welch NT, Parsons SL, James EJ, et al. Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer. Eur J Surg Oncol 2015;41:333-338. https://doi.org/10.1016/j.ejso.2014.11.040
  25. Miyamoto Y, Baba Y, Sakamoto Y, Ohuchi M, Tokunaga R, Kurashige J, et al. Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer. Ann Surg Oncol 2015;22:2663-2668. https://doi.org/10.1245/s10434-014-4281-6
  26. Peng P, Hyder O, Firoozmand A, Kneuertz P, Schulick RD, Huang D, et al. Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J Gastrointest Surg 2012;16:1478-1486. https://doi.org/10.1007/s11605-012-1923-5
  27. Awad S, Tan BH, Cui H, Bhalla A, Fearon KC, Parsons SL, et al. Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer. Clin Nutr 2012;31:74-77. https://doi.org/10.1016/j.clnu.2011.08.008
  28. Feliciano EMC, Kroenke CH, Meyerhardt JA, Prado CM, Bradshaw PT, Kwan ML, et al. Association of systemic inflammation and sarcopenia with survival in nonmetastatic colorectal cancer: results from the C SCANS study. JAMA Oncol 2017;3:e172319. https://doi.org/10.1001/jamaoncol.2017.2319

Cited by

  1. Diagnosis of Sarcopenia in Head and Neck Computed Tomography: Cervical Muscle Mass as a Strong Indicator of Sarcopenia vol.12, pp.3, 2018, https://doi.org/10.21053/ceo.2018.01613
  2. CT-assessed sarcopenia is a predictive factor for both long-term and short-term outcomes in gastrointestinal oncology patients: a systematic review and meta-analysis vol.19, pp.1, 2018, https://doi.org/10.1186/s40644-019-0270-0
  3. Association between preoperative potential sarcopenia and survival of cancer patients undergoing major surgical procedures vol.47, pp.None, 2020, https://doi.org/10.1590/0100-6991e-20202528
  4. Risks of Sarcopenia in Patients with Hematological and Oncological Factors who Underwent Hematopoietic Stem Cell Transplantation vol.57, pp.4, 2018, https://doi.org/10.2490/jjrmc.19001
  5. Thigh sarcopenia and hypoalbuminemia predict impaired overall survival after infrainguinal revascularization in patients with critical limb ischemia vol.28, pp.5, 2020, https://doi.org/10.1177/1708538120913745
  6. Pre‐operative low muscle mass is associated with major complications and lower recurrence‐free survival after gastric cancer surgery vol.91, pp.3, 2021, https://doi.org/10.1111/ans.16590
  7. Body Composition Changes in Gastric Cancer Patients during Preoperative FLOT Therapy: Preliminary Results of an Italian Cohort Study vol.13, pp.3, 2018, https://doi.org/10.3390/nu13030960
  8. AWGS2019 vs EWGSOP2 for diagnosing sarcopenia to predict long-term prognosis in Chinese patients with gastric cancer after radical gastrectomy vol.9, pp.18, 2021, https://doi.org/10.12998/wjcc.v9.i18.4668
  9. Impact of preoperative sarcopenia on postoperative complications and prognosis of gastric cancer resection: A meta-analysis of cohort studies vol.98, pp.None, 2018, https://doi.org/10.1016/j.archger.2021.104534